FI925261A0 - Vaord och diagnos av virushepatitis - Google Patents

Vaord och diagnos av virushepatitis

Info

Publication number
FI925261A0
FI925261A0 FI925261A FI925261A FI925261A0 FI 925261 A0 FI925261 A0 FI 925261A0 FI 925261 A FI925261 A FI 925261A FI 925261 A FI925261 A FI 925261A FI 925261 A0 FI925261 A0 FI 925261A0
Authority
FI
Finland
Prior art keywords
virushepatitis
vaord
diagnos
och
vaord och
Prior art date
Application number
FI925261A
Other languages
English (en)
Finnish (fi)
Other versions
FI925261A (fi
Inventor
William A Carter
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Publication of FI925261A publication Critical patent/FI925261A/fi
Publication of FI925261A0 publication Critical patent/FI925261A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI925261A 1990-05-25 1992-11-19 Vaord och diagnos av virushepatitis FI925261A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/528,962 US5132292A (en) 1990-05-25 1990-05-25 Treatment of viral hepatitis
PCT/US1991/003174 WO1991018611A1 (en) 1990-05-25 1991-05-08 Diagnosis and treatment of viral hepatitis

Publications (2)

Publication Number Publication Date
FI925261A FI925261A (fi) 1992-11-19
FI925261A0 true FI925261A0 (fi) 1992-11-19

Family

ID=24107946

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925261A FI925261A0 (fi) 1990-05-25 1992-11-19 Vaord och diagnos av virushepatitis

Country Status (13)

Country Link
US (1) US5132292A (xx)
EP (1) EP0531365A4 (xx)
JP (1) JP3208138B2 (xx)
CN (1) CN1059659A (xx)
AU (1) AU646050B2 (xx)
CA (1) CA2083603A1 (xx)
FI (1) FI925261A0 (xx)
HU (1) HUT65385A (xx)
IE (1) IE911782A1 (xx)
NZ (1) NZ238169A (xx)
PT (1) PT97749B (xx)
WO (1) WO1991018611A1 (xx)
ZA (1) ZA913949B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906980A (en) * 1987-07-17 1999-05-25 Hem Research Inc. Treatment of hepatitis with mismatched dsRNA
US5712257A (en) * 1987-08-12 1998-01-27 Hem Research, Inc. Topically active compositions of mismatched dsRNAs
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
US6521601B1 (en) * 1992-04-14 2003-02-18 Signal Pharmaceuticals, Inc. Method and composition for inhibition of viral replication
US5496546A (en) * 1993-02-24 1996-03-05 Jui H. Wang Compositions and methods of application of reactive antiviral polyadenylic acid derivatives
US6291438B1 (en) 1993-02-24 2001-09-18 Jui H. Wang Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
US20050137154A1 (en) * 2003-05-16 2005-06-23 Hemispherx Biopharma Treating server acute respiratory syndrome
GB0314824D0 (en) 2003-06-25 2003-07-30 Design Blue Ltd Energy absorbing material
DE202005004135U1 (de) * 2005-03-11 2005-05-19 Klocke Verpackungs-Service Gmbh Mehrkomponentenverpackung mit Applikator
US7943147B2 (en) * 2005-12-07 2011-05-17 Hemispherx Biopharma dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931397A (en) * 1971-11-05 1976-01-06 Beecham Group Limited Biologically active material
US4283393A (en) * 1979-03-13 1981-08-11 Merck & Co., Inc. Topical application of interferon inducers
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
AU1820588A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
ATE122402T1 (de) * 1987-09-04 1995-05-15 Hem Pharma Corp Diagnose von mangelzuständen doppelsträngiger rns.
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape

Also Published As

Publication number Publication date
AU646050B2 (en) 1994-02-03
JP3208138B2 (ja) 2001-09-10
PT97749B (pt) 1998-10-30
EP0531365A1 (en) 1993-03-17
CN1059659A (zh) 1992-03-25
FI925261A (fi) 1992-11-19
US5132292A (en) 1992-07-21
AU7879691A (en) 1991-12-31
HUT65385A (en) 1994-06-28
EP0531365A4 (en) 1993-09-15
JPH05507481A (ja) 1993-10-28
PT97749A (pt) 1992-02-28
ZA913949B (en) 1992-06-24
NZ238169A (en) 1997-07-27
CA2083603A1 (en) 1991-11-26
HU9203682D0 (en) 1993-04-28
WO1991018611A1 (en) 1991-12-12
IE911782A1 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
FI932960A (fi) Kontroll av frukters mogning och vaexters foeraoldring
FI923983A (fi) Kymotrypsinlika proteaser och deras inhibitorer
FI932285A0 (fi) Skyddshjaelm och loestagbart ansiktsskydd
FI932031A0 (fi) System och foerfarande foer behandling av biologiska vaetskor
FI925480A (fi) Vattenloeslig pentacyklisk triterpenkomposition och foerfarande foer framstaellning av densamma
FI925261A0 (fi) Vaord och diagnos av virushepatitis
FI88433C (fi) Anordning foer ingaongs- och utgaongsluft och luftkonditioneringsfoerfarande
FI931628A (fi) Identifieringsanordning och foerfarande foer saekerhetssystem
FI900031A0 (fi) Foerfarande och anordning foer behandling av gaser fraon foergasnings- eller foerbraenningsanlaeggningar.
FI932114A (fi) Maolspecifika erytrocyter och tromboerytrocyter
FI901486A (fi) Foerfarande och anordning foer behandling av en mineralfiberbana.
FI930002A0 (fi) Renings- och aotervinningsfoerfarande och anordning foer utfoerande av foerfarandet
FI925983A (fi) Maenniskans meg-csf-protein och foerfaranden
FI89089B (fi) Foerfarande och form foer gjutning av plattbelaeggning
FI900168A (fi) Foerfarande och anordning foer borning av kanaloeppning.
FI901114A0 (fi) Foerfarande och anordning foer avluftning av betong.
FI901001A0 (fi) Foerfarande och anordning foer framstaellning av metallmatriskomposit.
FI931065A (fi) Austenitiskt slitstarkt staol och foerfarande foer vaermebehandling av detta
FI900999A (fi) Anlaeggning foer framstaellning och anvaendning av betongmassa.
FI900020A0 (fi) Foerfarande och anordning foer visualisering av ultraljudsbild.
FI900692A (fi) Foerfarande och anordning foer bekaempning av oljeskador.
FI900001A (fi) Foerfarande och anordning foer behandling av betongyta.
FI900133A (fi) Foerfarande och anordning foer kompensering av oevertryck.
FI900103A0 (fi) Dielektrisk keramikkomposition foer mikrovaogsomraodet och anvaendning daer av.
FI901117A (fi) Foerfarande och anordning foer framstaellning av en transportskruv.

Legal Events

Date Code Title Description
FD Application lapsed